Pacira reports preliminary August net product sales of $59.1M; EXPAREL up 13% YoY

Pacira BioSciences, Inc.

Total net product sales of $59.1M for August 2022; EXPAREL $46.7M (vs $41.4M in Aug 2021).
EXPAREL average daily sales were 108% of Aug 2021; 23 selling days vs 22.
ZILRETTA contributed $9.7M; iovera° $1.5M (up from $0.9M); veterinary sales $1.2M.
More than 11 million patients have received EXPAREL since launch.
Company not providing 2022 revenue guidance due to COVID-19 and labor uncertainty.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.